FindTrial
Sign In

Evaluation of efficacy of harmonic scalpel in endoscope-assisted implant breast augmentation through axillary incision

Evaluation of efficacy of harmonic scalpel in endoscope-assisted implant breast augmentation through axillary incision

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066240
Enrollment
Unknown
Registered
2022-11-29
Start date
2022-01-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implant breast augmentation.

Interventions

experimental group:harmonic scalpel
control group:monopolar cautery

Sponsors

Plastic Surgery Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Adult women who planned to undergo endoscope-assisted implant breast augmentation through axillary incision and provided valid written informed consent.

Exclusion criteria

Exclusion criteria: (1) Take anticoagulant drugs or blood-activating drugs within 2 weeks before surgery; (2) Systemic or systemic diseases, such as immune or hematological diseases, liver and kidney dysfunction, etc.; (3) Abnormal judgment or cognitive ability; (4) drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
postoperative total drainage volume;—

Secondary

MeasureTime frame
postoperative drainage for 24 hours;postoperative drainage days;VAS score for postoperative pain;operative time;Reoperation rate;—

Countries

China

Contacts

Public ContactDali Mu

Plastic Surgery Hospital, Chinese Academy of Medical Sciences

doctormudali@hotmail.com13366001109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026